Quarterly report pursuant to Section 13 or 15(d)

Significant Accounting Policies (Details Textual)

v2.3.0.15
Significant Accounting Policies (Details Textual)
1 Months Ended 1 Months Ended 3 Months Ended 9 Months Ended 1 Months Ended
Feb. 28, 2011
USD ($)
Sep. 30, 2011
USD ($)
May 10, 2011
Apr. 28, 2011
Dec. 31, 2010
USD ($)
Sep. 30, 2010
USD ($)
Dec. 31, 2009
USD ($)
Feb. 28, 2011
Herbalife Venezuela's [Member]
Mar. 31, 2011
Herbalife Venezuela's [Member]
USD ($)
Sep. 30, 2011
Herbalife Venezuela's [Member]
VEF
Sep. 30, 2010
Herbalife Venezuela's [Member]
Dec. 31, 2010
Herbalife Venezuela's [Member]
USD ($)
Feb. 28, 2011
Herbalife Venezuela's [Member]
United States [Member]
VEF
Feb. 28, 2011
Herbalife Venezuela's [Member]
United States [Member]
USD ($)
Significant Accounting Policies (Textual) [Abstract]                            
Number of additional shares distributed to Company's shareholders for each share     1                      
Payments to acquire US denominated bonds                         86,000,000  
Proceeds from sale of US denominated bonds                           15,000,000
Average effective conversion rate               5.7            
SITME rate for remeasurement               5.3            
Cash and Cash Equivalents, at Carrying Value   261,521,000     190,550,000 193,490,000 150,801,000     29,000,000   16,300,000    
Net monetary Bolivar denominated assets and liabilities                   21,500,000        
Conversion resulted net pre-tax loss                 1,300,000          
Subsidiary's net sales to Company's consolidated net sales, percentage                   less than 2% less than 2%      
Subsidiary's total assets to Company's consolidated total assets, percentage                   less than 3%   less than 3%    
Face value of US denominated bonds $ 20,000,000                          
Basis of shares approved by shareholders       Two-for-one stock split